The orthopaedic services sector is one of the fastest-growing segments in the healthcare industry, with orthopaedic conditions generating more than 137 million annual provider visits, McGuireWoods writes in Lexology.
This surge in growth also holds true for investment interest and transactions in the space. Over the past several years, even throughout the slower months of early 2020 during the COVID-19 pandemic, orthopaedic deals have been highly sought after and highly competitive. Investor interest in this “hip” subsector is on the rise for many reasons, and with a high demand for services, increased movement to outpatient venues, and high-value ancillaries, investor interest in the orthopaedic sector is only expected to grow. Read more.
